Sen. John Boozman Unloads Shares of JPMorgan Chase & Co. (NYSE:JPM)

Senator John Boozman (Republican-Arkansas) recently sold shares of JPMorgan Chase & Co. (NYSE:JPM). In a filing disclosed on August 17th, the Senator disclosed that they had sold between $1,001 and $15,000 in JPMorgan Chase & Co. stock on July 23rd.

Senator John Boozman also recently made the following trade(s):

• Sold $1,001 – $15,000 in shares of Cboe Global Markets (BATS:CBOE) on 7/31/2026.
• Purchased $1,001 – $15,000 in shares of PayPal (NASDAQ:PYPL) on 7/30/2026.
• Purchased $1,001 – $15,000 in shares of State Street SPDR Portfolio S&P 500 ETF (NYSEARCA:SPYM) on 7/23/2026.
• Sold $1,001 – $15,000 in shares of Home Depot (NYSE:HD) on 7/9/2026.
• Purchased $1,001 – $15,000 in shares of Aptiv (NYSE:APTV) on 7/9/2026.
• Sold $1,001 – $15,000 in shares of Travelers Companies (NYSE:TRV) on 7/2/2026.
• Purchased $1,001 – $15,000 in shares of Chevron (NYSE:CVX) on 7/2/2026.
• Purchased $1,001 – $15,000 in shares of Estee Lauder Companies (NYSE:EL) on 7/2/2026.
• Purchased $1,001 – $15,000 in shares of abrdn Physical Palladium Shares ETF (NYSEARCA:PALL) on 6/25/2026.
• Purchased $1,001 – $15,000 in shares of iShares Expanded Tech-Software Sector ETF (BATS:IGV) on 6/25/2026.

JPMorgan Chase & Co. Stock Up 0.6%

Shares of NYSE:JPM opened at $363.30 on Wednesday. The business’s 50 day moving average is $342.14 and its 200 day moving average is $316.43. The stock has a market cap of $965.71 billion, a P/E ratio of 15.57, a price-to-earnings-growth ratio of 1.49 and a beta of 0.99. JPMorgan Chase & Co. has a 52-week low of $279.10 and a 52-week high of $366.50. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 1.30.

JPMorgan Chase & Co. (NYSE:JPM) last issued its earnings results on Tuesday, July 14th. The financial services provider reported $6.14 earnings per share for the quarter, topping the consensus estimate of $5.59 by $0.55. JPMorgan Chase & Co. had a return on equity of 18.23% and a net margin of 21.86%.The business had revenue of $58.02 billion during the quarter, compared to analysts’ expectations of $50.72 billion. During the same period in the prior year, the business earned $4.96 EPS. The business’s revenue for the quarter was up 27.7% compared to the same quarter last year. Sell-side analysts predict that JPMorgan Chase & Co. will post 24.28 EPS for the current year.

Institutional Trading of JPMorgan Chase & Co.

Several hedge funds and other institutional investors have recently made changes to their positions in JPM. Bank of America Corp DE increased its stake in JPMorgan Chase & Co. by 6.1% during the 2nd quarter. Bank of America Corp DE now owns 69,666,753 shares of the financial services provider’s stock valued at $22,804,018,000 after purchasing an additional 4,006,293 shares in the last quarter. Morgan Stanley lifted its stake in shares of JPMorgan Chase & Co. by 1.4% during the fourth quarter. Morgan Stanley now owns 66,385,268 shares of the financial services provider’s stock worth $21,390,662,000 after buying an additional 939,421 shares during the period. Norges Bank acquired a new stake in shares of JPMorgan Chase & Co. during the fourth quarter worth $11,396,496,000. Bank of New York Mellon Corp grew its holdings in shares of JPMorgan Chase & Co. by 5.4% during the fourth quarter. Bank of New York Mellon Corp now owns 23,424,482 shares of the financial services provider’s stock valued at $7,547,837,000 after buying an additional 1,194,583 shares during the last quarter. Finally, Legal & General Group Plc grew its holdings in shares of JPMorgan Chase & Co. by 0.6% during the fourth quarter. Legal & General Group Plc now owns 19,019,564 shares of the financial services provider’s stock valued at $6,128,484,000 after buying an additional 110,586 shares during the last quarter. Hedge funds and other institutional investors own 71.55% of the company’s stock.

Insider Buying and Selling at JPMorgan Chase & Co.

In related news, insider Robin Leopold sold 2,500 shares of the firm’s stock in a transaction on Tuesday, August 11th. The stock was sold at an average price of $361.41, for a total value of $903,525.00. Following the completion of the transaction, the insider owned 73,547 shares in the company, valued at $26,580,621.27. This trade represents a 3.29% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, General Counsel Stacey Friedman sold 5,467 shares of JPMorgan Chase & Co. stock in a transaction dated Monday, June 22nd. The stock was sold at an average price of $330.73, for a total value of $1,808,100.91. Following the sale, the general counsel directly owned 40,961 shares of the company’s stock, valued at approximately $13,547,031.53. This represents a 11.78% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.41% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of analysts recently weighed in on JPM shares. Keefe, Bruyette & Woods upped their price objective on shares of JPMorgan Chase & Co. from $370.00 to $384.00 and gave the stock an “outperform” rating in a research note on Wednesday, July 15th. Wells Fargo & Company raised their target price on shares of JPMorgan Chase & Co. from $375.00 to $390.00 and gave the company an “overweight” rating in a research report on Friday. Robert W. Baird boosted their price target on shares of JPMorgan Chase & Co. from $295.00 to $305.00 and gave the company a “neutral” rating in a report on Wednesday, July 15th. Truist Financial upped their price target on shares of JPMorgan Chase & Co. from $344.00 to $352.00 and gave the stock a “hold” rating in a research report on Wednesday, July 15th. Finally, Citigroup increased their price objective on shares of JPMorgan Chase & Co. from $325.00 to $360.00 and gave the company a “neutral” rating in a research note on Monday, July 20th. One investment analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating and eleven have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $359.96.

Key Stories Impacting JPMorgan Chase & Co.

Here are the key news stories impacting JPMorgan Chase & Co. this week:

• Positive Sentiment: Wells Fargo reportedly sees JPMorgan reaching the historic $1 trillion valuation milestone within days and believes the bank could potentially double its market value over the next seven to eight years. The forecast reinforces the bullish “Jamie premium” surrounding CEO Jamie Dimon’s long-term leadership. Wells Fargo makes aggressive JPMorgan prediction
• Positive Sentiment: Recent analyst commentary highlights JPMorgan’s earnings resilience, broad business mix and price strength versus competitors such as Truist, despite JPM’s less-discounted valuation and lower dividend yield. Its latest quarterly results also showed substantial revenue growth and an earnings beat. JPMorgan vs. Truist
• Positive Sentiment: JPMorgan is expanding its customer and wealth-management footprint, including a new Chicago flagship combining Chase banking with J.P. Morgan Private Client services. The bank plans more than 160 new branches and nearly 600 renovations in 2026, supporting long-term deposit, lending and fee growth. JPMorganChase opens Chicago flagship
• Positive Sentiment: The bank continues developing growth initiatives across blockchain payments, housing finance and institutional lending. It is also reportedly part of a lending syndicate supporting Anthropic’s pre-IPO financing, which could provide investment-banking and financing fees, although the direct earnings impact is unclear. JPMorgan housing, bonds and blockchain expansion
• Neutral Sentiment: J.P. Morgan Life Sciences Private Capital appointed Bruce N. Rogers, Ph.D., as a venture partner. The move strengthens the asset-management unit’s investment expertise but is unlikely to materially affect near-term JPM earnings. J.P. Morgan Life Sciences Private Capital appointment
• Negative Sentiment: Jamie Dimon cautioned the U.K. government against imposing tougher bank taxes, warning that higher costs could reduce financial-sector employment and competitiveness. Similar policy pressure remains a regulatory risk for JPMorgan’s international operations. Dimon cautions against tougher UK bank taxes
• Negative Sentiment: JPMorgan strategists and executives warned of potential global food inflation and questioned whether parts of the artificial-intelligence investment boom resemble the excesses preceding the 2008 housing crash. These warnings could increase investor caution around inflation, credit and market valuations, though they are not direct indications of deterioration at JPMorgan. JPMorgan executive warns on AI boom

About Senator Boozman

John Boozman (Republican Party) is a member of the U.S. Senate from Arkansas. He assumed office on January 3, 2011. His current term ends on January 3, 2029. Boozman (Republican Party) ran for re-election to the U.S. Senate to represent Arkansas. He won in the general election on November 8, 2022. Boozman won re-election in 2016. He faced Democrat Conner Eldridge, Libertarian Frank Gilbert, and write-in candidate Jason Tate in the general election. Arkansas’ U.S. Senate race was rated as safely Republican in 2016. Boozman began his political career in the U.S. House. He won a special election in 2001 and served in that position until his election to the Senate in 2010. Prior to his political career, Boozman worked as an optometrist. As of a 2014 analysis of multiple outside rankings, Boozman is an average Republican member of Congress, meaning he will vote with the Republican Party on the majority of bills. Below is an abbreviated outline of Boozman’s academic, professional, and political career: 2011-Present: U.S. Senator from Arkansas 2001-2011: U.S. Representative from Arkansas 1977: Graduated from Southern College of Optometry

JPMorgan Chase & Co. Company Profile

JPMorgan Chase & Co (NYSE: JPM) is a diversified global financial services firm headquartered in New York City. The company provides a wide range of banking and financial products and services to consumers, small businesses, corporations, governments and institutional investors worldwide. Its operations span retail banking, commercial lending, investment banking, asset management, payments and card services, and treasury and securities services.

The firm’s principal business activities are organized across several core lines: Consumer & Community Banking, which offers deposit accounts, mortgages, auto loans, credit cards and branch and digital banking under the Chase brand; Corporate & Investment Banking, which provides capital markets, advisory, underwriting, trading and risk management services; Commercial Banking, delivering lending, treasury and capital solutions to middle-market and corporate clients; and Asset & Wealth Management, which offers investment management, private banking and retirement services to institutions and high-net-worth individuals.